Acute vitamin B12 supplementation evokes antidepressant response and alters Ntrk-2.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
07 2020
Historique:
received: 04 12 2019
revised: 15 04 2020
accepted: 17 04 2020
pubmed: 27 4 2020
medline: 29 6 2021
entrez: 27 4 2020
Statut: ppublish

Résumé

Depression is the leading cause of disability worldwide. Although most research into risk factors focuses on stress, dietary factors also have a strong link with depression. For instance, chronic vitamin B12-supplementation may reduce depression risk and helps to reverse the prodepressive effects of early life stress in animal models. However, it is still unclear whether a single acute dose of vitamin B12 is sufficient to induce antidepressant effects on molecular or behavioral levels. Based on pharmacological work and CRISPR-dCas9 epigenome editing in Neuro2A-cells we provide in vitro evidence for a link between vitamin B12, gene expression and DNA methylation of the antidepressant-associated gene Ntrk-2, which codes for the BDNF-receptor TRKB. Using stress-induction protocols in C57Bl/6 J mice combined with behavioral testing and subsequent molecular tissue analysis, we establish in vivo evidence for antidepressant effects of vitamin B12. Acute supplementation with vitamin B12, but not folic acid, selectively altered DNA methylation and gene expression of Ntrk-2 in vitro, albeit DNA methylation and Ntrk-2 gene expression do not correlate in vivo. Importantly, one acute vitamin B12 injection improved multiple behavioral measures in tests for antidepressant action and at the same time reversed the effects of chronic and acute stress on Ntrk-2 levels in vivo, however causality has not been proven at this stage. Taken together, acute vitamin B12 supplementation can reverse stress effects on Ntrk-2 gene expression and improve behaviors that are associated with depression-like behavior in mice. Our findings encourage further investigation of vitamin B12-supplementation as a novel model for antidepressant action.

Identifiants

pubmed: 32335151
pii: S0028-3908(20)30180-5
doi: 10.1016/j.neuropharm.2020.108112
pii:
doi:

Substances chimiques

Antidepressive Agents 0
Membrane Glycoproteins 0
Ntrk2 protein, mouse EC 2.7.10.1
Protein-Tyrosine Kinases EC 2.7.10.1
Receptor, trkB EC 2.7.10.1
Vitamin B 12 P6YC3EG204

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108112

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no competing interests to declare or interests to disclose.

Auteurs

Charlotte Trautmann (C)

Institut für Humangenetik, Jena University Hospital, Am Klinikum 1, F4E20, 07747, Jena, Germany.

Andrea Bock (A)

Institut für Humangenetik, Jena University Hospital, Am Klinikum 1, F4E20, 07747, Jena, Germany.

Anja Urbach (A)

Institut für Neurologie, Jena University Hospital, Am Klinikum 1, F4E20, 07747, Jena, Germany.

Christian A Hübner (CA)

Institut für Humangenetik, Jena University Hospital, Am Klinikum 1, F4E20, 07747, Jena, Germany.

Olivia Engmann (O)

Institut für Humangenetik, Jena University Hospital, Am Klinikum 1, F4E20, 07747, Jena, Germany; Laboratory of Neuroepigenetics, University of Zürich and ETH Zürich, Center for Neuroscience Zürich, Brain Research Institute, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland. Electronic address: olivia.engmann@med.uni-jena.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH